Clinical Trial Update: Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intravenous rhTNK-tPA before thrombectomy for acute ischemic stroke in an extended time window is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• rhTNK-tPA (tenecteplase)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Stroke, Acute Ischemic | Phase 3 | Status: RECRUITING